Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-IFIT2 antibody (200-280 aa) (STJ190316) | Login | Anti-IFIT2 antibody (200-280 aa) (STJ190316) | ||||||||||||||||
|
||||||||||||||||||
Anti-IFIT3 antibody (330-410 aa) (STJ190317) | Login | Anti-IFIT3 antibody (330-410 aa) (STJ190317) | ||||||||||||||||
|
||||||||||||||||||
Anti-IFIT1B antibody (10-90 aa) (STJ190330) | Login | Anti-IFIT1B antibody (10-90 aa) (STJ190330) | ||||||||||||||||
|
||||||||||||||||||
Anti-ITFG2 antibody (40-120 aa) (STJ190342) | Login | Anti-ITFG2 antibody (40-120 aa) (STJ190342) | ||||||||||||||||
|
||||||||||||||||||
Anti-KDM5A antibody (720-800 aa) (STJ190343) | Login | Anti-KDM5A antibody (720-800 aa) (STJ190343) | ||||||||||||||||
|
||||||||||||||||||
Anti-AFF4 antibody (30-110 aa) (STJ190525) | Login | Anti-AFF4 antibody (30-110 aa) (STJ190525) | ||||||||||||||||
|
||||||||||||||||||
Anti-KRT83 antibody (50-130 aa) (STJ190357) | Login | Anti-KRT83 antibody (50-130 aa) (STJ190357) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA4 antibody (70-150 aa) (STJ190358) | Login | Anti-MAGEA4 antibody (70-150 aa) (STJ190358) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA10 antibody (70-150 aa) (STJ190359) | Login | Anti-MAGEA10 antibody (70-150 aa) (STJ190359) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB1 antibody (70-150 aa) (STJ190360) | Login | Anti-MAGEB1 antibody (70-150 aa) (STJ190360) | ||||||||||||||||
|
||||||||||||||||||
Anti-BCL6B antibody (100-180 aa) (STJ190428) | Login | Anti-BCL6B antibody (100-180 aa) (STJ190428) | ||||||||||||||||
|
||||||||||||||||||
Anti-PITX3 antibody (10-90 aa) (STJ190186) | Login | Anti-PITX3 antibody (10-90 aa) (STJ190186) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDKL5 antibody (30-110 aa) (STJ190188) | Login | Anti-CDKL5 antibody (30-110 aa) (STJ190188) | ||||||||||||||||
|
||||||||||||||||||
Anti-SATB2 antibody (650-730 aa) (STJ190433) | Login | Anti-SATB2 antibody (650-730 aa) (STJ190433) | ||||||||||||||||
|
||||||||||||||||||
Anti-TNIP3 antibody (40-120 aa) (STJ190437) | Login | Anti-TNIP3 antibody (40-120 aa) (STJ190437) | ||||||||||||||||
|
||||||||||||||||||
Anti-FMR1NB antibody (180-260 aa) (STJ190438) | Login | Anti-FMR1NB antibody (180-260 aa) (STJ190438) | ||||||||||||||||
|
||||||||||||||||||
Anti-ID1 antibody (30-110 aa) (STJ190197) | Login | Anti-ID1 antibody (30-110 aa) (STJ190197) | ||||||||||||||||
|
||||||||||||||||||
Anti-POU3F3 antibody (90-170 aa) (STJ190442) | Login | Anti-POU3F3 antibody (90-170 aa) (STJ190442) | ||||||||||||||||
|
||||||||||||||||||
Anti-GTF2A2 antibody (30-110 aa) (STJ190199) | Login | Anti-GTF2A2 antibody (30-110 aa) (STJ190199) | ||||||||||||||||
|
||||||||||||||||||
Anti-EFNB2 antibody (210-290 aa) (STJ190200) | Login | Anti-EFNB2 antibody (210-290 aa) (STJ190200) | ||||||||||||||||
|
||||||||||||||||||
Anti-SNRPD3 antibody (30-110 aa) (STJ190202) | Login | Anti-SNRPD3 antibody (30-110 aa) (STJ190202) | ||||||||||||||||
|
||||||||||||||||||
Anti-MRPS11 antibody (10-90 aa) (STJ190204) | Login | Anti-MRPS11 antibody (10-90 aa) (STJ190204) | ||||||||||||||||
|
||||||||||||||||||
Anti-HSD3B1 antibody (30-110 aa) (STJ190453) | Login | Anti-HSD3B1 antibody (30-110 aa) (STJ190453) | ||||||||||||||||
|
||||||||||||||||||
Anti-COASY antibody (260-340 aa) (STJ190213) | Login | Anti-COASY antibody (260-340 aa) (STJ190213) | ||||||||||||||||
|
||||||||||||||||||
Anti-MTF1 antibody (260-340 aa) (STJ190218) | Login | Anti-MTF1 antibody (260-340 aa) (STJ190218) | ||||||||||||||||
|